...FDA granted 510(k) clearance for the ProAdeno+ assay from Gen-Probe's Prodesse Inc. subsidiary as an aid in...

...FDA granted 510(k) clearance for the ProFast+ assay from Gen-Probe's Prodesse Inc. subsidiary to detect and differentiate...

...FDA granted 510(k) clearance for the ProParaflu+ assay from Gen-Probe's Prodesse Inc. subsidiary for use to detect...

...Gen-Probe completed its previously announced acquisition of molecular diagnostic company Prodesse for $60 million in cash...
...$25 million in potential milestones (see BioCentury, Oct. 12). Gen-Probe Inc. (NASDAQ:GPRO), San Diego, Calif. Prodesse Inc....

...was off $1.09 to $41.72 last week after FDA granted an emergency use authorization for Prodesse...

...FDA granted an emergency use authorization (EUA) for Gen-Probe's Prodesse ProFlu-ST to diagnose swine influenza A...
...test through its acquisition of Prodesse Inc. last month. Gen-Probe Inc. (NASDAQ:GPRO), San Diego, Calif. Product: Prodesse...

...FDA granted an emergency use authorization (EUA) for Prodesse ProFlu-ST from Gen-Probe Inc. (NASDAQ:GPRO) to diagnose...
...set to expire on April 26, 2010. Gen-Probe gained the test through its acquisition of Prodesse Inc....

...Gen-Probe will acquire molecular diagnostic company Prodesse for $60 million in cash on hand, plus up...
...for $60 million in cash on hand, plus up to $25 million in potential milestones. Prodesse...
...month. XMS Capital Partners and Leerink Swann advised Prodesse. Gen-Probe Inc. (NASDAQ:GPRO), San Diego, Calif. Prodesse Inc....

...FDA granted 510(k) clearance to Prodesse for the ProFlu+ assay to detect influenza A virus, influenza...
...from a patient's respiratory secretions. The company said the test has been made commercially available. Prodesse Inc....

...IVGN granted Prodesse a nonexclusive worldwide license to use its LUX (light upon extension) technology to...
...eligible for milestones and royalties. Further terms were not disclosed. Invitrogen Corp. (IVGN), Carlsbad, Calif. Prodesse Inc....